文献速递免疫规划

鼻内接种疫苗对幼年虹鳟(Oncorhynchus mykiss)肠型红嘴病(ERM)与传染性造血器官坏死病(IHN)的长期效力

Long-term efficacy of nasal vaccination against enteric red mouth (ERM) disease and infectious hematopoietic necrosis (IHN) in juvenile rainbow trout (Oncorhynchus mykiss).
PubMed 文献 · Vaccine · 2021-12-07

研究评估了幼年虹鳟经鼻内(I.N.)与注射途径接种灭活肠型红嘴病(ERM)菌苗和减毒传染性造血器官坏死病病毒(IHNV)疫苗后6个月和12个月的效力与免疫应答。6个月攻毒时,I.N.接种减毒IHNV疫苗组累积死亡率最低,显示长期保护不依赖全身IgM应答;而I.N.接种ERM菌苗未产生显著保护,作者建议在6个月前加强免疫。

要点

  • I.N.接种减毒IHNV疫苗在6个月攻毒时累积死亡率最低,显示长期保护。
  • I.N.接种ERM菌苗在6个月攻毒时未产生显著保护,作者建议6个月前加强免疫。
  • I.N.接种减毒IHNV疫苗的保护不依赖于全身特异性IgM应答。

核心结论

  • I.N.接种减毒IHNV疫苗可提供长期保护,而I.N.接种ERM菌苗不能,作者建议在6个月前加强免疫。

研究设计与样本

  • 幼年虹鳟分别经I.P.和I.N.途径接种Y. ruckeri菌苗,经I.M.和I.N.途径接种减毒IHNV疫苗,在6个月攻毒并检测6个月和12个月的免疫应答。

主要发现

  • I.P.接种ERM菌苗组在6个月时血清特异性IgM滴度显著高于模拟接种组,且持续升高;12个月时所有处理组对Y. ruckeri的抗体滴度无显著差异。
  • 6个月Y. ruckeri攻毒后,I.P.接种组累积死亡率与对照组有显著差异,而I.N.接种组无显著差异。
  • I.M.和I.N.接种减毒IHNV疫苗在6个月和12个月均未诱导显著特异性血清IgM滴度。
  • I.N.接种减毒IHNV疫苗组在6个月攻毒时累积死亡率最低,表明长期保护与全身IgM应答不相关。
  • 12个月时脾脏VH-JH重排 repertoire 分析证实存在独特扩增,且随疫苗类型和接种途径而异。

临床怎么用

  • 作者建议在6个月前对虹鳟进行加强免疫以维持对ERM的保护。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Previous research demonstrated that bacterial and viral vaccines delivered via the nasal route in rainbow trout (Oncorhynchus mykiss) at 7 and 28 days post-vaccination are highly protective (>95% protection). Long-term protection following nasal vaccination in teleosts has not been evaluated. The goal of this study was to assess efficacy and immune responses at 6 months (mo) post-vaccination (mpv), and long-lasting immune responses at 12 mpv of two different vaccines: an inactivated enteric red mouth disease (ERM) Yersinia ruckeri bacterin and a live attenuated infectious hematopoietic necrosis virus (IHNV) vaccine. Juvenile rainbow trout were vaccinated for Y. ruckeri via intraperitoneal (I.P.) and intranasal (I.N.) routes, and for IHNV by intramuscular (I.M.) and I.N. routes, then challenged at 6 mpv. Immune responses were determined at 6 and 12 mpv. ERM vaccine I.P. delivery elicited significantly higher serum IgM-specific titers that remained elevated compared to mock-vaccinated fish at 6 mpv. By 12 mpv, antibody titers to Y. ruckeri were not significantly different across all treatments. Following Y. ruckeri challenge at 6 mpv, a significant difference in cumulative percent mortality (CPM) was found for I.P.-vaccinated fish but not I.N.-vaccinated fish. I.M. and I.N. vaccination with live attenuated IHNV did not result in significant specific serum IgM titers at 6 or 12 mpv. Yet, I.N.-vaccinated fish showed the lowest CPM 6 mpv indicating long-term protection that does not correlate with systemic IgM responses. Repertoire analyses confirmed unique expansions of VH-JH rearrangements in the spleen of rainbow trout 12 mpv that varied with the type of vaccine and route of vaccination. Combined, these data demonstrate that I.N. vaccination with a live attenuated viral vaccine confers long lasting protection, but I.N. ERM vaccination does not and booster before 6 mpv is recommended.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Ma J, Casadei E, Bruce TJ, et al. Long-term efficacy of nasal vaccination against enteric red mouth (ERM) disease and infectious hematopoietic necrosis (IHN) in juvenile rainbow trout (Oncorhynchus mykiss). Vaccine. 2021. PMID: 34893343. doi:10.1016/j.vaccine.2021.11.077

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。